June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
hiPSCs - derived Retinal Organoids as a model system for Organic Retinal Prosthesis
Author Affiliations & Notes
  • Alessandro Bellapianta
    Center for Medical Research, Faculty of Medicine, University Clinic for Ophthalmology and Optometry, Johannes Kepler Universitat Linz, Linz, Austria
  • Ana Cetkovic
    Center for Medical Research, Faculty of Medicine, University Clinic for Ophthalmology and Optometry, Johannes Kepler Universitat Linz, Linz, Austria
  • Mihai Irimia-Vladu
    Johannes Kepler Universitat Linz Institut fur Physikalische Chemie und Linzer Institut fur organische Solarzellen, Linz, Oberösterreich, Austria
  • Markus Clark Scherber
    Johannes Kepler Universitat Linz Institut fur Physikalische Chemie und Linzer Institut fur organische Solarzellen, Linz, Oberösterreich, Austria
  • Matthias Bolz
    Center for Medical Research, Faculty of Medicine, University Clinic for Ophthalmology and Optometry, Johannes Kepler Universitat Linz, Linz, Austria
  • Ahmad Salti
    Center for Medical Research, Faculty of Medicine, University Clinic for Ophthalmology and Optometry, Johannes Kepler Universitat Linz, Linz, Austria
  • Footnotes
    Commercial Relationships   Alessandro Bellapianta None; Ana Cetkovic None; Mihai Irimia-Vladu None; Markus Scherber None; Matthias Bolz None; Ahmad Salti None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3202. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alessandro Bellapianta, Ana Cetkovic, Mihai Irimia-Vladu, Markus Clark Scherber, Matthias Bolz, Ahmad Salti; hiPSCs - derived Retinal Organoids as a model system for Organic Retinal Prosthesis. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3202.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Organic semiconductor polymers are encouraging materials for retinal prostheses, due to their key prosthetic features such as flexibility, light sensitivity and biocompatibility. A hindering problem remains to find the appropriate human model for pre-clinical research. Through the differentiation of human induced pluripotent stem cells (hiPSCs) to self-organized three dimensional (3D) retinal organoids (ROs), it is now possible to model the spatio-temporal development of the human retina and recapitulate in vitro the human (patho)physiology. In this context, we hypothesize that ROs can be used as human in vitro model to test the efficiency of novel organic retinal prosthesis.

Methods : Two hiPSCs lines, one carrying a disease causing mutation on the PRPF31 gene and a healthy control; have been differentiated into ROs following a 2D/3D approach, treated with BMP4 from d6 to d15. On d30 the 3D structures with optic vesicle and lamination-like appearance were picked off and placed in suspension with retinoic acid until d100. ROs were collected at various time points and characterized through immunofluorescence, qPCR and flow cytometry for pluripotency, progenitor and photoreceptor markers. RO function was assessed via microelectrode arrays. The organic semiconductor layers were processed from solution using the spin-coating and vapor deposition techniques.

Results : We confirmed the pluripotency of the hiPSC lines for TRA-1-60, OCT4 and NANOG and the presence of the PRPF31 deletion. Late ROs showed a decrease in progenitor markers (KI67 and PAX6), an increase in early and late photoreceptor markers (OTX2, CRX, RCVRN, OPSIN), ganglion and amacrine cell markers (HuC and Brn3b), and bipolar cell marker (PKCa). Proper retinal layer organization was observed and functional electrical firing was recorded. ROs kept in direct contact with organic materials showed no cytotoxicity by apoptosis analysis.

Conclusions : With the discovery of iPSCs and their differentiation into 3D organoids, a new horizon of human in vitro models arose. ROs bridge the gap between animal experimental models and 2D cultures. Our results so far indicate that ROs represent a proper human in vitro model as assessed by cellular, molecular and functional analysis. Further investigation is underway to confirm their suitability as human models for organic prosthesis.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×